Editor/NN
’/CD
s/NNS
Introduction/NN
to/TO
This/DT
Issue/NN
(/(
G/NN
&/CC
I/NN
16:2/CD
,/,
2018/CD
)/)
./.
====================
This/DT
issue/NN
covers/VBZ
two/CD
original/JJ
articles/NNS
on/IN
mutation/NN
analysis/NN
and/CC
one/CD
original/JJ
article/NN
on/IN
the/DT
identification/NN
of/IN
a/DT
rare/JJ
disease/NN
gene/NN
./.
====================
In/IN
the/DT
article/NN
by/IN
Dr./NNP
Dong-Uk/NNP
Kim/NN
and/CC
Dr./NNP
Kwang-Lae/NN
Hoe/NN
,/,
the/DT
authors/NNS
report/VBP
the/DT
frequency/NN
and/CC
type/NN
of/IN
mutations/NNS
in/IN
synthetic/JJ
DNA/NN
barcodes/NNS
that/DT
are/VBP
incorporated/VBN
into/IN
the/DT
genome/NN
of/IN
fission/NN
yeast/NN
./.
====================
They/PRP
had/VBD
previously/RB
reported/VBD
the/DT
construction/NN
of/IN
a/DT
gene/NN
deletion/NN
library/NN
of/IN
fission/NN
yeast/NN
./.
====================
Mutations/NNS
in/IN
DNA/NN
barcodes/NNS
might/MD
cause/VB
serious/JJ
problems/NNS
in/IN
microarray/NN
experiments/NNS
./.
====================
The/DT
comprehensive/JJ
characterization/NN
of/IN
mutations/NNS
by/IN
this/DT
study/NN
will/MD
guide/NN
the/DT
proper/JJ
application/NN
of/IN
the/DT
library/NN
./.
====================
Dr./NNP
Yeun-Jun/NN
Chung/JJ
’/CD
s/NNS
group/NN
compared/VBD
mutations/NNS
in/IN
primary/JJ
colorectal/JJ
tumors/NNS
and/CC
the/DT
corresponding/JJ
xenograft/NN
tumors/NNS
./.
====================
The/DT
patient-derive/JJ
xenograft/NN
(/(
PDX/NN
)/)
has/VBZ
been/VBN
recognized/VBN
as/IN
an/DT
important/JJ
tool/NN
for/IN
finding/NN
the/DT
most/JJS
appropriate/JJ
personalized/VBN
treatment/NN
for/IN
each/DT
cancer/NN
patient/NN
./.
====================
Its/PRP$
biggest/JJS
issue/NN
is/VBZ
how/WRB
often/RB
the/DT
mutation/NN
in/IN
the/DT
cancer/NN
tissue/NN
disappears/VBZ
or/CC
how/WRB
frequently/RB
new/JJ
mutations/NNS
occur/VBP
during/IN
the/DT
process/NN
of/IN
PDX/NN
generation/NN
./.
====================
In/IN
this/DT
paper/NN
,/,
the/DT
authors/NNS
show/VBP
that/IN
most/JJS
somatic/JJ
mutations/NNS
and/CC
copy/NN
number/NN
alterations/NNS
are/VBP
maintained/VBN
in/IN
the/DT
PDX/NN
./.
====================
These/DT
results/NNS
are/VBP
important/JJ
data/NNS
that/WDT
support/VBP
the/DT
implementation/NN
of/IN
PDX/NN
in/IN
precision/NN
medicine/NN
./.
====================
Dr./NNP
Jong-Keuk/NNP
Lee/NNP
's/POS
group/NN
and/CC
the/DT
Korean/JJ
Kawasaki/NNP
Disease/NN
Genetics/NNS
Consortium/NN
show/VBP
that/IN
Kawasaki/NNP
disease/NN
in/IN
children/NN
aged/JJ
younger/RBR
than/IN
6/CD
months/NNS
,/,
which/WDT
is/VBZ
not/RB
a/DT
common/JJ
age/NN
of/IN
onset/NN
,/,
is/VBZ
significantly/RB
associated/VBN
with/IN
a/DT
rare/JJ
nonsynonymous/JJ
single-nucleotide/JJ
polymorphism/NN
in/IN
the/DT
lymphoid/JJ
enhancer-binding/JJ
factor/NN
1/CD
(/(
LEF1/NN
)/)
gene/NN
in/IN
a/DT
genome-wide/JJ
association/NN
study/NN
and/CC
a/DT
follow-up/JJ
replication/NN
study/RB
./.
====================
It/PRP
is/VBZ
interesting/JJ
that/IN
similar/JJ
patterns/NNS
,/,
although/IN
not/RB
statistically/RB
significant/JJ
,/,
were/VBD
observed/VBN
in/IN
the/DT
Japanese/JJ
patient/NN
group/NN
./.
====================
This/DT
study/NN
may/MD
provide/VB
new/JJ
insights/NNS
into/IN
the/DT
pathogenesis/NN
of/IN
Kawasaki/NN
disease/NN
if/IN
further/RBR
association/NN
studies/NNS
using/VBG
more/RBR
patient/NN
samples/NNS
and/CC
gene/NN
function/NN
analysis/NN
are/VBP
performed/VBN
./.
====================
For/IN
further/RBR
details/VBZ
,/,
please/NN
visit/FW
the/DT
G/NN
&/CC
I/NN
homepage/NN
(/(
https/NNS
:/:
//genominfo.org//JJ
)/)
./.
====================
